Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats

Journal of Applied Toxicology

Volumn 17, Issue 6, 1997, Pages 409-413

  Ewis, Soliman A ^a   Abdel Rahman, Mohamed S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Atenolol; Diabetes; Glutathione; Magnesium; Metformin

Indexed keywords

ATENOLOL; GLUTATHIONE; MAGNESIUM; METFORMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATIONS; GLUTATHIONE; HYPOGLYCEMIC AGENTS; LIVER; MAGNESIUM; MALE; METFORMIN; MYOCARDIUM; ORGAN SIZE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030732909     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199711/12)17:6<409::AID-JAT462>3.0.CO;2-B     Document Type: Article

References (32)

1. J. D Swales, Hypertension and diabetes Pract Diabetes 7, 56-59 (1990).
2. K. M. Epstein and J. R. Sower, Diabetes and hypertension. Hypertension 19, 404-418 (1992).
3. M. Laakso and H. Sarlund, Essential hypertension and insulin resistance in NIDD. Eur. J. Clin Invest. 19, 518-526 (1989)
4. American Diabetes Association Consensus Statement, Hypertension in diabetes. Diabetes Care 16, 1394-1401 (1993).
5. N. Kaplawitz, M. Ookthens and T W. Aw, The regulation of hepatic glutathione. Annu Rev. Pharmacol. Toxicol. 25, 715-744 (1985)
6. E. C. Cross, B. Holliwell, E T. Borscin, W. A. Pryor, R N. Ames, R. L. Saul, J. M McCord and D. Haman, Oxygen radicals and human disease. Annu. Intern Med. 107, 526-545 (1987).
7. F. Z. Meerson, V E Kagan, Yu Kozlov, L. M Belika and Y. V. Artripenko, The role of lipid protection in the pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res. Cardiol. 77, 465-485 (1982).
8. A. W. Saleh and V G. David, Alteration in free radical tissue - defense mechanism in streptozocin-induced diabetes in rat. Diabetes 36, 1014-1018 (1987)
9. B. J Mills, R. D. Linderman and C A. Long, Magnesium deficiency inhibits biosynthesis of blood glutathione and turnover growth in the rat (42260) Proc Soc. Exp. Biol. Med. 181, 326-331 (1986)
10. B. E. Nordin, Plasma calcium and plasma magnesium homeostasis In Calcium, Phosphate and Magnesium Metabolism, Clinical Physiology and Diagnostic Procedures, ed by B E. Nordin, p 280. Churchill Livingstone, London (1976).
11. American Diabetes Association Consensus Statement, Magnesium supplementation of diabetes. Diabetes Care 16 (Suppl. 2), 79-81 (1993)
12. A. Sjogren, L. Edvinson and B Fallgen, Magnesium deficiency in coronary artery disease and cardiac arrhythmia. Intern. Med. 226, 213-222 (1989)
13. A. Berthelot and J Esposlto, Effect of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat. J. Am Coll. Nutr 4, 343-353 (1983).
14. B. F. Dicken, W B. Weglicki, Y. S Li and I T Mak, Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells FEBS Lett. 311 (3), 187-191 (1992)
15. P. Gluseppe, D Anna, G Dario, C. Antonio, V Mickele and D. Felice, Pharmacological doses of Vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients Am J. Clin Nutr 57, 650-656 (1993)
16. A H Atrakchl, B. F. Dickens, W. B Weglicki and S. Bloom, Prubucol reduces severity of isoprotrenol and Mg-deficiency induced myocardial lesions (abstract). Pharmacologist 30, A150 (1988).
17. A. H. Atrakchl, W. B. Weglicki and S. Bloom, Beta blocker protects against magnesium-deficiency-induced cardiac injury (abstract). FASEB J. 4, 4035 (1989).
18. K. Landink and U. Smith, Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors J. Int. Med. 229, 181-186 (1991).
19. S. Mathaei and H. Greten, Evidence that Metformin ameliorates cellular insulin resistance by potentiating plasma membrane Diabetes Met. 17, 150-155 (1991).
20. I. G. Fantus and R. Brossen, Mechanism of action of metformin: insulin receptor and post receptor effects in vitro and in vivo. J. Clin. Endocr. Met. 63, 898-905 (1986).
21. S.A. Ewis and M.S. Abdel-Rahman, Effect of metformin on glutathione and magnesium in normal and streptozocin diabetic rats. J Appl. Toxicol. 15, 387-390 (1995).
22. M. L. Tuck, Diabetes and hypertension Postgrad. Med. J. 64 (Suppl. 3), 125-133 (1988).
23. American Diabetes Association Consensus Statement, Treatment of hypertension in diabetes. Diabetes Care 19 (Suppl. 1), 107-113 (1996).
24. Charles River Technical Bulletin, Vol 3, p. 2. Charles River Laboratories, Wilmington, MA (1984).
25. M. W. Bradbry, C R. Kleeman, H. Bagdoyan and A. Berberian, The calcium and magnesium content of skeletal muscle, brain and cerebrospinal fluid as determined by atomic absorption flame photometry. J. Lab. Clin. Med. 71, 884-892 (1968).
26. E. Beutler, O. Buran and B. M. Kelly, Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61, 882-888 (1963).
27. The Diabetes Control and Complications Trial Research Group, The effective of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986 (1993).
28. Z T. Bloomgarden, The American Diabetes Association Annual Meeting, 1994: treatment issue for NIDDM. Diabetes Care 17, 1078-1084 (1994).
29. D. G. McDevit and A. M. McConnachi, Antianginal and beta adrenoreceptor blocker drugs. In Meyler's Side Effects of Drugs, ed. by M. N G. Dukes, pp. 360-371. Elsevier Science Publishers, Amsterdam (1988).
30. J L. Brandet, W Glaser and A. Lones, Soft tissue distribution and plasma disappearance of intravenously administrated isotopic magnesium with observation on uptake in bone. Metabolism 7, 355-363 (1958).
31. C J. Baily, Metformin revisited: its actions and indications for use Diabetes Med. 5, 315-320 (1988).
32. I. Dorup and T Clasen, Effect of magnesium and zinc deficiencies on growth and protein synthesis in skeletal muscle and the heart Br J. Nutr. 66, 493-504 (1991).